The company is also advancing its engineered stem cell antibody paired evasion (ESCAPE) conditioning strategy to face the toxicity ... indications like ATTR amyloidosis and hereditary angioedema.

CRISPR Therapeutics CRSP stock rose more than 25% in the past week, thanks to the encouraging fourth-quarter 2024 results and ...

The approval is based on results from the phase 3 ATTRibute-CM study trial showing ... for which Filspari is currently approved and is starting to face more competition, according to Leerink ...

Art Still has ATTR amyloidosis, an inherited heart condition that dramatically impacts Black men and the former Kansas City ...

An intriguing battle is brewing in the market to treat patients with transthyretin amyloid cardiomyopathy (ATTR-CM). | BridgeBio reported that 1,028 unique prescriptions have been written by 516 ...

Four years after getting the first drug approved by the FDA to treat rare disease hereditary ATTR amyloidosis, Alnylam has got the go-ahead for a second – Amvuttra – which has a simpler ...

AstraZeneca has clearly made the rare disease transthyretin amyloidosis (ATTR) a key component of its rare disease pipeline, licensing a second drug candidate in the space of a couple of months.

A Phase III trial evaluating nex-z in transthyretin amyloidosis with cardiomyopathy is underway, with plans for another ...

CRISPR Therapeutics CRSP stock rose more than 25% in the past week, thanks to the encouraging fourth-quarter 2024 results and a rating upgrade by a Wall Street analyst. Though CRSP’s quarterly ...

After its Season 2 renewal in February 2023, Rian Johnson’s and Natasha Lyonne’s Poker Face, the case-of-the-week mystery series, is back in production for its next installment. Season 1 of ...